Intestinally derived lipids: Metabolic regulation and consequences-An overview

Atherosclerosis Supplements

Volumn 9, Issue 2, 2008, Pages 63-68

  Cianflone, Katherine ^a,b   Paglialunga, Sabina ^a,b   Roy, Christian ^b  

^a MCGILL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Acylation stimulating protein; C3adesArg; G protein coupled receptor; Postprandial lipemia

Indexed keywords

ABC TRANSPORTER A1; ACYLATION STIMULATING PROTEIN; CHOLESTEROL; CHYLOMICRON; FATTY ACID; FATTY ACID BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; INSULIN; LIPID; LIPOPROTEIN LIPASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PROTEIN; PROTEIN FABP2; PROTEIN NPC1L1; SCAVENGER RECEPTOR BI; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ARTICLE; DIET; DRUG TARGETING; ENERGY EXPENDITURE; ESTERIFICATION; FAT TOLERANCE TEST; HYPERLIPIDEMIA; INTESTINE; INTESTINE CELL; KNOCKOUT MOUSE; LIPID ABSORPTION; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; LIPID TRANSPORT; LIVER; METABOLIC REGULATION; MUSCLE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CARRIER PROTEINS; DYSLIPIDEMIAS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; HUMANS; INTESTINAL ABSORPTION; INTESTINES; MICROSOMES; POSTPRANDIAL PERIOD;

EID: 50449099848     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2008.05.014     Document Type: Article

References (60)

1. Bosner M.S., Lange L.G., Stenson W.F., and Ostlund Jr. R.E. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J Lipid Res 40 (1999) 302-308
2. Graham T.E. Exercise, postprandial triacylglyceridemia, and cardiovascular disease risk. Can J Appl Physiol 29 (2004) 781-799
3. Velázquez M.E., Bellabarba G.A., Mendoza S., and Sánchez L. Postprandial triglyceride response in patients with polycystic ovary syndrome: relationship with waist-to-hip ratio and insulin. Fertil Steril 74 (2000) 1159-1163
4. Zhang B., Matsunaga A., Saku K., Nakano S., and Yamada T. Associations among plasma lipoprotein subfractions as characterized by analytical capillary isotachophoresis, apolipoprotein E phenotype, Alzheimer's disease, and mild cognitive impairment. Arterioscler Thromb Vasc Biol 24 (2004) e144-e146
5. Keller T.T., van Leuven S.I., Meuwese M.C., et al. Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler Thromb Vasc Biol 26 (2006) 2345-2350
6. Kolovou G.D., Anagnostopoulou K.K., Daskalopoulou S.S., Mikhailidis D.P., and Cokkinos D.V. Clinical relevance of postprandial lipaemia. Curr Med Chem 12 (2005) 1931-1945
7. Slivkoff-Clark K., James A.P., Kerr D., Soares M.J., and Mamo J.C. The effect of diet standardization on postprandial chylomicron response. Asia Pac J Clin Nutr 13 (2004) S69
8. Agren J.J., Hallikainen M., Vidgren H., Miettinen T.A., and Gylling H. Postprandial lipemic response and lipoprotein composition in subjects with low or high cholesterol absorption efficiency. Clin Chim Acta 366 (2006) 309-315
9. Hegele R.A., Harris S.B., Hanley A.J., et al. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab 81 (1996) 4334-4337
10. Georgopoulos A., Aras O., and Tsai M.Y. Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J Clin Endocrinol Metab 85 (2000) 3155-3160
11. Wetterau J.R., Aggerbeck L.P., Bouma M.E., et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 258 (1992) 999-1001
12. Meier J.J., Gethmann A., Gotze O., et al. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia 49 (2006) 452-458
13. Helwig U., Rubin D., Klapper M., et al. The association of fatty acid-binding protein 2 A54T polymorphism with postprandial lipemia depends on promoter variability. Metabolism 56 (2007) 723-731
14. Gambino R., Cassader M., Pagano G., Durazzo M., and Musso G. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in non-alcoholic steatohepatitis?. Hepatology 45 (2007) 1097-1107
15. Phillips C., Mullan K., Owens D., and Tomkin G.H. Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition. Atherosclerosis 187 (2005) 57-64
16. Lally S., Tan C.Y., Owens D., and Tomkin G.H. Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein. Diabetologia 49 (2006) 1008-1016
17. Murphy K.G., Dhillo W.S., and Bloom S.R. Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev 27 (2006) 719-727
18. Meier J.J., Nauck M.A., Pott A., et al. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology 130 (2006) 44-54
19. Picard F., Naimi N., Richard D., and Deshaies Y. Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion. Diabetes 48 (1999) 452-459
20. Faraj M., Lu H.L., and Cianflone K. Diabetes, lipids, and adipocyte secretagogues. Biochem Cell Biol 82 (2004) 170-190
21. Bergö M., Olivecrona G., and Olivecrona T. Forms of lipoprotein lipase in rat tissues: in adipose tissue the proportion of inactive lipase increases on fasting. Biochem J 313 (1996) 893-898
22. Bergö M., Olivecrona G., and Olivecrona T. Diurnal rhythms and effects of fasting and refeeding on rat adipose tissue lipoprotein lipase. Am J Physiol 271 (1996) E1092-E1097
23. Lee J.J., Smith P.J., and Fried S.K. Mechanisms of decreased lipoprotein lipase activity in adipocytes of starved rats depend on duration of starvation. J Nutr 128 (1998) 940-946
24. Robinson L.E., and Graham T.E. Metabolic syndrome-a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity. Can J Appl Physiol 29 (2004) 808-829
25. Warne J.P. Tumour necrosis factor alpha-a key regulator of adipose tissue mass. J Endocrinol 177 (2003) 351-355
26. Faraj M., and Cianflone K. Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP. Am J Physiol Endocrinol Metab 287 (2004) E150-E159
27. Cuenca J., Perez C.A., Aguirre A.J., Schiattino I., and Aguillon J.C. Genetic polymorphism at position-308 in the promoter region of the tumor necrosis factor (TNF): implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population. Biol Res 34 (2001) 237-241
28. Miles J.M., Park Y.S., Walewicz D., et al. Systemic and forearm triglyceride metabolism: fate of lipoprotein lipase-generated glycerol and free fatty acids. Diabetes 53 (2004) 521-527
29. Cianflone K., Xia Z., and Chen L.Y. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 1609 (2003) 127-143
30. Kalant D., Cain S.A., Maslowska M., et al. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. J Biol Chem 278 (2003) 11123-11129 [Erratum in: J Biol Chem 2004;279:820].
31. Kalant D., MacLaren R., Cui W., et al. C5L2 is a functional receptor for acylation-stimulating protein. J Biol Chem 280 (2005) 23936-23944
32. Maslowska M., Legakis H., Assadi F., and Cianflone K. Targeting the signaling pathway of acylation stimulating protein. J Lipid Res 47 (2006) 643-652
33. Cancello R., and Clément K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 113 (2006) 1141-1147
34. Faraj M., Sniderman A.D., and Cianflone K. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. J Lipid Res 45 (2004) 657-666
35. Wu Y, Zhang J, Wen Y, et al. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertil Steril 2008 Jan 16 [Epub ahead of print].
36. Yu H., Yang Y., Zhang M., et al. Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab 3 (2006) 13
37. Tang JH, Wen Y, Wu F, et al. Increased plasma acylation-stimulating protein in pediatric proteinuric renal disease. Pediatr Nephrol 2008 Feb 6 [Epub ahead of print].
38. Yang Y., Lu H.L., Zhang J., et al. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs. obese type 2 diabetes. Int J Obes 30 (2006) 439-446
39. Schrauwen P., Hesselink M.K., Jain M., and Cianflone K. Acylation-stimulating protein: effect of acute exercise and endurance training. Int J Obes 29 (2005) 632-638
40. Cianflone K., Zakarian R., Couillard C., et al. Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. J Lipid Res 45 (2004) 124-131
41. Murray I., Sniderman A.D., Havel P.J., and Cianflone K. Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. J Biol Chem 274 (1999) 36219-36225
42. Murray I., Havel P.J., Sniderman A.D., and Cianflone K. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 141 (2000) 1041-1049
43. Paglialunga S., Fisette A., Yan Y., et al. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice. Am J Physiol Endocrinol Metab 294 (2008) E521-E529
44. Paglialunga S., Schrauwen P., Roy C., et al. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. J Endocrinol 194 (2007) 293-304
45. Xia Z., Stanhope K.L., Digitale E., et al. Acylation-stimulating protein (ASP)/complement C3adesArg deficiency results in increased energy expenditure in mice. J Biol Chem 279 (2004) 4051-4057
46. Xia Z., Sniderman A.D., and Cianflone K. Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. J Biol Chem 277 (2002) 45874-45879
47. Roy C., Paglialunga S., Fisette A., et al. Shift in metabolic fuel in acylation stimulating protein (ASP)-deficient mice following a high-fat diet. Am J Physiol Endocrinol Metab. 294 (2008) E1051-E1059
48. St Clair R.W., and Beisiegel U. What do all the apolipoprotein E receptors do?. Curr Opin Lipidol 8 (1997) 243-245
49. Lambert J.C., Brousseau T., Defosse V., et al. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. Hum Mol Genet 9 (2000) 57-61
50. Van Eck M., Pennings M., Hoekstra M., Out R., and Van Berkel T.J. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr Opin Lipidol 16 (2005) 307-315
51. Guerra R., Wang J., Grundy S.M., and Cohen J.C. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U.S.A 94 (1997) 4532-4537
52. Gómez P., Miranda J.L., Marín C., et al. Influence of the -514C/T polymorphism in the promoter of the hepatic lipase gene on postprandial lipoprotein metabolism. Atherosclerosis 174 (2004) 73-79
53. Willnow T.E. Mechanisms of hepatic chylomicron remnant clearance. Diabet Med 14 Suppl 3 (1997) S75-80
54. Kolovou G., Daskalova D., Anagnostopoulou K., et al. Postprandial hypertriglyceridaemia in patients with Tangier disease. J Clin Pathol 56 (2003) 937-941
55. Orsó E., Broccardo C., Kaminski W.E., et al. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat Genet 24 (2000) 192-196
56. Schaefer E.J., Brousseau M.E., Diffenderfer M.R., et al. Cholesterol and apolipoprotein B metabolism in Tangier disease. Atherosclerosis 159 (2001) 231-236
57. Sniderman A.D., Zhang Z., Genest J., and Cianflone K. Effects on apoB-100 secretion and bile acid synthesis by redirecting cholesterol efflux from HepG2 cells. J Lipid Res 44 (2003) 527-532
58. Matikainen N., Mänttäri S., Westerbacka J., et al. Postprandial lipemia associates with liver fat content. J Clin Endocrinol Metab 92 (2007) 3052-3059
59. Musso G., Gambino R., Durazzo M., et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 42 (2005) 1175-1183
60. Masaki T., Chiba S., Tatsukawa H., et al. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology 40 (2004) 177-184